This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,988.66, is for the provision of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract has an ultimate completion date of December 31, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside designation, indicating open competition. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/31/25, 9:36 AM